Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE, MA / ACCESS Newswire / February 17, 2026 / ...

Moderna expects to make mNEXSPIKE available in Europe pending regulatory timelines and local market access pathways. "We welcome the European Commission's decision, which reflects the strength of the ...

Messenger RNA specialist Moderna's R&D spend sunk by nearly a third last year, a drop attributed in part to the wind-down of major phase 3 respiratory trials. In 2025, Moderna spent $3.1 billion on ...

The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...

Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. As of publication, Moderna has not responded to Fierce Biotech’s questions about a ...

Starting today, millions of Americans who received the Moderna and Johnson & Johnson vaccines can get their booster shot. The Centers for Disease Control and Prevention's endorsed the boosters late ...